Nkarta Inc NKX101 Clinical Update Conference Call Transcript
Thank you for standing by. Welcome to the Nkarta conference call to review the clinical update for NKX101. (Operator Instructions) Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to the company.
Thank you, operator and good morning, everyone. I'm Greg Mann, SVP of Public Affairs and Investor Relations at Nkarta. Thank you for joining our call this morning. Earlier today, Nkarta issued a press release announcing updated clinical data from the clinical trial of NKX101. This press release, today's webcast and corresponding slides are available on our website. We're looking forward to discussing these results as we advance the next generation of cell therapies for cancer patients.
On the call today from Nkarta are Paul Hastings, President and Chief Executive Officer; Dr. David Shook, Chief Medical Officer; and Dr. Nadir Mahmood, Chief Financial and Business Officer. We're also honored to be joined by one of our distinguished
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |